- Home
- ATXS vs TREE Comparison
ATXS vs TREE Comparison
Compare ATXS & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- TREE
- Stock Information
- Founded
- ATXS 2008
- TREE 1996
- Country
- ATXS United States
- TREE United States
- Employees
- ATXS N/A
- TREE N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- TREE Finance: Consumer Services
- Sector
- ATXS Health Care
- TREE Finance
- Exchange
- ATXS Nasdaq
- TREE Nasdaq
- Market Cap
- ATXS 669.8M
- TREE 712.1M
- IPO Year
- ATXS 2015
- TREE N/A
- Fundamental
- Price
- ATXS $9.37
- TREE $44.34
- Analyst Decision
- ATXS Strong Buy
- TREE Buy
- Analyst Count
- ATXS 5
- TREE 8
- Target Price
- ATXS $25.60
- TREE $64.00
- AVG Volume (30 Days)
- ATXS 219.2K
- TREE 387.2K
- Earning Date
- ATXS 11-13-2024
- TREE 10-31-2024
- Dividend Yield
- ATXS N/A
- TREE N/A
- EPS Growth
- ATXS N/A
- TREE N/A
- EPS
- ATXS N/A
- TREE N/A
- Revenue
- ATXS N/A
- TREE $773,050,000.00
- Revenue This Year
- ATXS N/A
- TREE $32.88
- Revenue Next Year
- ATXS N/A
- TREE $16.82
- P/E Ratio
- ATXS N/A
- TREE N/A
- Revenue Growth
- ATXS N/A
- TREE 4.44
- 52 Week Low
- ATXS $4.26
- TREE $15.69
- 52 Week High
- ATXS $16.90
- TREE $62.49
- Technical
- Relative Strength Index (RSI)
- ATXS 30.44
- TREE 37.28
- Support Level
- ATXS $11.40
- TREE $46.50
- Resistance Level
- ATXS $11.75
- TREE $55.00
- Average True Range (ATR)
- ATXS 0.75
- TREE 4.37
- MACD
- ATXS -0.23
- TREE -0.34
- Stochastic Oscillator
- ATXS 7.64
- TREE 5.25
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About TREE LendingTree Inc.
LendingTree Inc is a United States-based company that is principally engaged in operating an online loan marketplace. The company provides online tools and resources that can help consumers find loans or other credit-based offerings They need, including mortgage loans, reverse mortgage, home equity, personal loans, auto loans, credit cards, student loans, small business loans, and other related offerings. The company offers consumers direct access to a broad range of lenders. They have three reportable segments which are Home, Consumer, and Insurance. The company generates match fees by matching consumers with lenders, and closing fees from lenders on loans when a transaction is closed. The company operates business solely in the United States.